John M. Evans
Director, CEO · 5 filings · Latest: Oct 15, 2026
Beam Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BEAM | John M. Evans | Director, CEO | Jan 30, 2026 | Sale | $28.36 | 25,000 | $708.9K | 986,667 | |
BEAM | John M. Evans | Director, CEO | Jan 30, 2026 | Option Exercise | $0.67 | 25,000 | $16.8K | 1,011,667 | |
BEAM | John M. Evans | Director, CEO | Jan 29, 2026 | Sale | $29.38 | 25,000 | $734.6K | 986,667 | |
BEAM | John M. Evans | Director, CEO | Jan 29, 2026 | Option Exercise | $0.67 | 25,000 | $16.8K | 1,011,667 | |
BEAM | JOHN M EVANS | — | Jan 30, 2026 | Proposed Sale | $28.36 | 25,000 | $708.9K | — | |
BEAM | JOHN M EVANS | — | Jan 29, 2026 | Proposed Sale | $29.38 | 25,000 | $734.6K | — | |
BEAM | JOHN M EVANS | — | Oct 2, 2025 | Proposed Sale | $24.63 | 25,000 | $615.7K | — | |
BEAM | JOHN M EVANS | — | Oct 1, 2025 | Proposed Sale | $24.51 | 25,000 | $612.7K | — | |
BEAM | JOHN M. EVANS | — | Apr 1, 2025 | Proposed Sale | $22.21 | 64,842 | $1.4M | — | |
BEAM | JOHN M EVANS | — | Jan 30, 2025 | Proposed Sale | $26.75 | 30,000 | $802.5K | — | |
BEAM | JOHN M EVANS | — | Sep 30, 2024 | Proposed Sale | $24.60 | 60,000 | $1.5M | — |
← Previous
Page 2 of 2